These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 22301049
1. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab. Ueda M, Katoh M, Tanizaki H, Tanioka M, Matsumura Y, Miyachi Y. Dermatol Online J; 2012 Jan 15; 18(1):12. PubMed ID: 22301049 [Abstract] [Full Text] [Related]
4. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review. Juillerat P, Christen-Zäch S, Troillet FX, Gallot-Lavallée S, Pannizzon RG, Michetti P. Dermatology; 2007 Jan 15; 215(3):245-51. PubMed ID: 17823524 [Abstract] [Full Text] [Related]
5. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis. Fernández A, Velasco A, Prieto V, Canueto J, Alvarez A, Rodríguez A. Am J Gastroenterol; 2008 Nov 15; 103(11):2951-2. PubMed ID: 19032482 [No Abstract] [Full Text] [Related]
7. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab. López San Román A, Bermejo F, Aldanondo I, Carrera E, Boixeda D, Muñoz Zato E. Rev Esp Enferm Dig; 2004 Jun 15; 96(6):420-2; 422-4. PubMed ID: 15230672 [Abstract] [Full Text] [Related]
9. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis. Teich N, Klugmann T. J Crohns Colitis; 2014 Jan 15; 8(1):85-6. PubMed ID: 23810275 [No Abstract] [Full Text] [Related]
10. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody. Dini V, Romanelli M, Bertone M, Talarico S, Bombardieri S, Barachini P. Int J Low Extrem Wounds; 2007 Jun 15; 6(2):108-13. PubMed ID: 17558009 [Abstract] [Full Text] [Related]
11. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Kouklakis G, Moschos J, Leontiadis GI, Kadis S, Mpoumponaris A, Molyvas E, Minopoulos GI. Rom J Gastroenterol; 2005 Dec 15; 14(4):401-3. PubMed ID: 16400359 [Abstract] [Full Text] [Related]
12. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis. Castro-Fernández M, Sánchez-Muñoz D, Ruíz-Granados E, Merchante N, Corzo J. Am J Gastroenterol; 2007 Dec 15; 102(12):2865-6. PubMed ID: 18042124 [No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum and ulcerative colitis in the tropics. Alese OB, Irabor DO. Rev Soc Bras Med Trop; 2008 Dec 15; 41(6):664-7. PubMed ID: 19142449 [Abstract] [Full Text] [Related]
14. [Ulcerative colitis associated with pyoderma gangrenosum]. Tusnádi A, Uhrin K, Bényei M, Krasznai G. Orv Hetil; 1994 Apr 24; 135(17):917-9. PubMed ID: 7909938 [Abstract] [Full Text] [Related]
15. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis]. Lorincz M, Kleszky M, Szalóki T, Szalóki T. Orv Hetil; 2010 Jan 24; 151(4):144-7. PubMed ID: 20071320 [Abstract] [Full Text] [Related]
16. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Marzano AV, Tourlaki A, Alessi E, Caputo R. Clin Exp Dermatol; 2008 Mar 24; 33(2):156-9. PubMed ID: 18021268 [Abstract] [Full Text] [Related]
17. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease. Zaccagna A, Bertone A, Puiatti P, Picciotto F, Sprujevnik T, Santucci R, Rossini FP. Eur J Dermatol; 2003 Mar 24; 13(3):258-60. PubMed ID: 12804985 [Abstract] [Full Text] [Related]
18. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine. Futami H, Kodaira M, Furuta T, Hanai H, Kaneko E. J Gastroenterol; 1998 Jun 24; 33(3):408-11. PubMed ID: 9658322 [Abstract] [Full Text] [Related]
19. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis. Ermis F, Ozdil S, Akyüz F, Pinarbasi B, Mungan Z. Inflamm Bowel Dis; 2008 Nov 24; 14(11):1611-3. PubMed ID: 18401859 [No Abstract] [Full Text] [Related]
20. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents. Duchini G, Itin P, Arnold A. Adv Skin Wound Care; 2011 May 24; 24(5):217-20. PubMed ID: 21505282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]